EP4013385
Bættar lípíð nanóagnir til dreifingar á kjarnsýrum
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
14.8.2020EP published:
3.7.2024EP application number:
20765121.7
EP translation filed:
16.9.2024Grant published:
15.10.2024EPO information:
European Patent Register
Max expiry date:
13.8.2040Expiry date:
13.8.2026
Title in English:
IMPROVED LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDSLanguage of the patent:
English
Timeline
Today
14.8.2020EP application
3.7.2024EP Publication
16.9.2024Translation submitted
15.10.2024Registration published
13.8.2026Expires
Owner
Name:
Acuitas Therapeutics, Inc.Address:
6190 Agronomy Road Suite 402 University of British Columbia - KETR, Vancouver, British Columbia V6T 1W5, CA
Inventor
Name:
TAM, Ying, K.Address:
Vancouver, British Columbia V6S 1C3, CA
Name:
LIN, Paulo, Jia, ChingAddress:
Vancouver, British Columbia V5S 1Y4, CA
Name:
SEMPLE, SeanAddress:
Vancouver, British Columbia V6T 1W5, CA
Name:
BARBOSA, Christopher, J.Address:
Coquitlam, British Columbia V3J 4Z8, CA
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962886894 PDate:
14.8.2019Country:
US
Classification
Categories:
A61K 9/00, A61K 9/127
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 22.8.2024
Expires: 13.8.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 7.8.2025
Expires: 13.8.2026
Payer: Árnason Faktor ehf.